• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Corticosteroid foam moves beyond scalp psoriasis

Maui, Hawaii - Already FDA-approved for scalp psoriasis, clobetasol propionate foam is effective against mild to moderate psoriasis in other parts of the body as well.

Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Maximizing the 2-Fold Benefits of Your Charitable Donations
November 26th 2024

Maximizing the 2-Fold Benefits of Your Charitable Donations

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Baricitinib Shows Superior Efficacy Versus Traditional Alopecia Treatments
November 25th 2024

Baricitinib Shows Superior Efficacy Versus Traditional Alopecia Treatments

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Heart Transplant Recipients are More Susceptible to Skin Cancer
November 25th 2024

Heart Transplant Recipients are More Susceptible to Skin Cancer

Protagonist Introduces Oral Peptide IL-17 Antagonist PN-881
November 25th 2024

Protagonist Introduces Oral Peptide IL-17 Antagonist PN-881

© 2024 MJH Life Sciences

All rights reserved.